Programs To Support You During Chemotherapy
Public ClinicalTrials.gov record NCT02489422. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
GI 1549: PROGRAMS TO SUPPORT YOU DURING CHEMOTHERAPY (PRO-YOU) A Randomized Controlled Pilot Study of Yoga Compared to an Attention Control in Patients Receiving Chemotherapy
Study identification
- NCT ID
- NCT02489422
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Enrollment
- 44 participants
Conditions and interventions
Conditions
- Anal Cancer
- Appendix Cancer
- Biliary Tract Cancer
- Depression
- Esophageal Cancer
- Fatigue
- Gallbladder Cancer
- Gastrointestinal Stromal Cancer
- Large Intestine Cancer
- Liver Cancer
- Pancreatic Cancer
- Small Intestine Cancer
- Stage IIA Colorectal Cancer
- Stage IIB Colorectal Cancer
- Stage IIC Colorectal Cancer
- Stage IIIA Colorectal Cancer
- Stage IIIB Colorectal Cancer
- Stage IIIC Colorectal Cancer
- Stage IVA Colorectal Cancer
- Stage IVB Colorectal Cancer
- Stomach Cancer
Interventions
- Actigraphy Assessment Other
- Attention Control Behavioral
- Daily Survey Administration Other
- Laboratory Biomarker Analysis Other
- Questionnaire Administration Other
- Yoga Skills Training Behavioral
Other · Behavioral
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2016
- Primary completion
- Dec 31, 2019
- Completion
- Dec 31, 2019
- Last update posted
- Oct 13, 2022
2016 – 2020
United States locations
- U.S. sites
- 2
- U.S. states
- 2
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Wake Forest Baptist Comprehensive Cancer Center | Winston-Salem | North Carolina | 27157 | — |
| Vanderbilt University/Ingram Cancer Center | Nashville | Tennessee | 37232 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02489422, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 13, 2022 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02489422 live on ClinicalTrials.gov.